WallStreetZenWallStreetZen

NASDAQ: ALVR
Allovir Inc Earnings & Revenue

ALVR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$168.9M
Current Profit Margin
0%

ALVR Return on Equity

Current Company
-80.2%
Current Industry
15.4%
Current Market
-8.4%
ALVR's Return on Equity (-80.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALVR announces earnings.

ALVR Return on Assets

Current Company
-64.2%
Current Industry
2.2%
ALVR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALVR Return on Capital Employed

Current Company
-78.64%
Current Industry
17.7%
ALVR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALVR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALVR$0.00-$164.13M-$168.86MN/AN/A
TSBXN/AN/AN/AN/AN/A
AFMD$20.23M-$120.04M-$126.78M+61.07%N/A
SPRO$77.70M$1.06M-$1.61M+88.47%-64.99%
MURAN/AN/AN/AN/AN/A

Allovir Earnings & Revenue FAQ

What were ALVR's earnings last quarter?

On Invalid Date, Allovir (NASDAQ: ALVR) reported Q3 2023 earnings per share (EPS) of -$0.39, up 22% year over year. Total Allovir earnings for the quarter were -$44.27 million. In the same quarter last year, Allovir's earnings per share (EPS) was -$0.50.

If you're new to stock investing, here's how to buy Allovir stock.

What was ALVR's earnings growth in the past year?

As of Q1 2024, Allovir's earnings has grown year over year. Allovir's earnings in the past year totalled -$168.86 million.

What was ALVR's revenue last quarter?

On Invalid Date, Allovir (NASDAQ: ALVR) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Allovir's revenue was $0.00.

What was ALVR's revenue growth in the past year?

As of Q1 2024, Allovir's revenue has grown null year over year. Allovir's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.